Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study

Abstract Background Hemodialysis patients are among high-risk groups for COVID-19. Africa is the continent with the lowest number of cases in the general population but we have little information about the disease burden in dialysis patients. Objectives This study aimed to describe the seroprevalenc...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Sidy Mohamed Seck, Moustapha Mbow, Yaya Kane, Mouhamadou Moustapha Cisse, Gnagna Faye, Adama Kama, Moussa Sarr, Pamela Nitcheu, Mohamed Dahaba, Ibrahima Mbemba Diallo, Mame Selly Diawara, Lotingo Nehemie Motoula Latou, Yacine Dia, Souleymane Mboup
Format:	article
Langue:	EN
Publié:	BMC 2021
Sujets:	SARS-CoV-2 COVID-19 Seroprevalence Hemodialysis Senegal Diseases of the genitourinary system. Urology RC870-923
Accès en ligne:	https://doaj.org/article/9f8c8dadb70148b4a893b7be4b1e684b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study

Documents similaires